C. G. M. Kallenberg

12.5k citations

74 papers · 7.2k indexed · 2 hit papers · h-index 35

Pulmonary and Respiratory Medicine top 0.2%
Rheumatology top 0.1%
Physiology top 0.5%
Immunology top 1%
Genetics top 0.5%

Co-authors: Gary S. Hoffman P A Bacon Jacob Churg J. Charles Jennette Robert T. McCluskey Wolfgang L. Gross Ronald J. Falk Leendert A. van Es
Topics: Vasculitis and related conditions (32 papers)Systemic Lupus Erythematosus Research (19 papers)Renal Diseases and Glomerulopathies (8 papers)
Cited by: Rheumatology Pulmonary and Respiratory Medicine Nephrology
Journals: The Lancet The Journal of Experimental Medicine Annals of the New York Academy of Sciences
Partner nations: Netherlands United States Italy

In The Last Decade

C. G. M. Kallenberg

74 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nomenclature of Systemic Vasculitides

1994 2.7k citations J. Charles Jennette, Ronald J. Falk et al. Arthritis & Rheumatism profile →
EULAR recommendations for the management of primary small and medium vessel vasculitis

2008 618 citations Chetan Mukhtyar, Loı̈c Guillevin et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by C. G. M. Kallenberg

Since Specialization

Citations

This map shows the geographic impact of C. G. M. Kallenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. G. M. Kallenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. G. M. Kallenberg more than expected).

Fields of papers citing papers by C. G. M. Kallenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. G. M. Kallenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. G. M. Kallenberg. The network helps show where C. G. M. Kallenberg may publish in the future.

Co-authorship network of co-authors of C. G. M. Kallenberg

This figure shows the co-authorship network connecting the top 25 collaborators of C. G. M. Kallenberg. A scholar is included among the top collaborators of C. G. M. Kallenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. G. M. Kallenberg. C. G. M. Kallenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis 2012 ·Autoimmunity Reviews ·Alexandre Wagner Silva de Souza,Johanna Westra,P. C. Limburg,Marc Bijl,C. G. M. Kallenberg	120
2	Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double‐blind, placebo‐controlled trial 2010 ·Arthritis & Rheumatism ·J Meijer,P. Meiners,Arjan Vissink,Fred K. L. Spijkervet,Wayel H. Abdulahad,Noëlle G. A. Kamminga,Elisabeth Brouwer,C. G. M. Kallenberg,Hendrika Bootsma	319
3	EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases 2010 ·Annals of the Rheumatic Diseases ·Sander van Assen,Nancy Agmon‐Levin,Ori Elkayam,Ricard Cervera,Michele F. Doran,Maxime Dougados,Paul Emery,P. Geborek,John P. A. Ioannidis,David Jayne,C. G. M. Kallenberg,Ulf Müller‐Ladner,Yehuda Shoenfeld,Ljudmila Stojanovich,Guido Valesini,Nico Wulffraat,Marc Bijl	443
4	EULAR recommendations for the management of primary small and medium vessel vasculitisbreakdown → 2008 ·Annals of the Rheumatic Diseases ·Chetan Mukhtyar,Loı̈c Guillevin,María C. Cid,Bhaskar Dasgupta,Kirsten de Groot,Wolfgang L. Gross,Thomas Häuser,Bernhard Hellmich,David Jayne,C. G. M. Kallenberg,Peter A. Merkel,H. Raspe,Carlo Salvarani,(unknown),Coen A. Stegeman,Richard A. Watts,Kerstin Westman,James Witter,Hasan Yazıcı,Raashid Luqmani	618
5	Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients 2007 ·Annals of the Rheumatic Diseases ·Esther Reefman,Hilde Kuiper,P. C. Limburg,C. G. M. Kallenberg,Marc Bijl	58
6	Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome 2006 ·Lara D. Veeken ·Justin Pijpe,W. Kalk,Jacqueline E. van der Wal,Arjan Vissink,Ph. M. Kluin,Jan L.N. Roodenburg,H. Bootsma,C. G. M. Kallenberg,F. K. L. Spijkervet	127
7	Rituximab treatment in patients with primary Sjögren's syndrome: An open‐label phase II study 2005 ·Arthritis & Rheumatism ·Justin Pijpe,Gustaaf W. van Imhoff,Fred K. L. Spijkervet,Jan L.N. Roodenburg,Gertjan Wolbink,Khaled Mansour,Arjan Vissink,C. G. M. Kallenberg,Hendrika Bootsma	356
8	Sialometry and sialochemistry: a non-invasive approach for diagnosing Sjögren's syndrome 2002 ·Annals of the Rheumatic Diseases ·W Kalk,Arjan Vissink,Bauke T. Stegenga,Hendrika Bootsma,A. van Nieuw Amerongen,C. G. M. Kallenberg	74
9	Clinical aspects of primary vasculitis 2001 ·Springer Seminars in Immunopathology ·Coen A. Stegeman,C. G. M. Kallenberg	9
10	Fc? receptor polymorphisms in Wegener's granulomatosis: Risk factors for disease relapse 1999 ·Arthritis & Rheumatism ·Hilde M. Dijstelbloem,(unknown),(unknown),Coen A. Stegeman,W. Ludo van der Pol,Wim J. Sluiter,C. G. M. Kallenberg,Jan G. J. van de Winkel,Jan Willem Cohen Tervaert	88
11	Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis 1998 ·Kidney International ·Peter Heeringa,Elisabeth Brouwer,Jan Willem Cohen Tervaert,Jan J. Weening,C. G. M. Kallenberg	67
12	Nomenclature of Systemic Vasculitidesbreakdown → 1994 ·Arthritis & Rheumatism ·J. Charles Jennette,Ronald J. Falk,K. Andrássy,P A Bacon,Jacob Churg,Wolfgang L. Gross,E. Christiaan Hagen,Gary S. Hoffman,Gene G. Hunder,C. G. M. Kallenberg,Robert T. McCluskey,Renato Alberto Sinico,(unknown),Leendert A. van Es,Rüdiger Waldherr,Allan Wiik	2694
13	LONG-TERM FOLLOW-UP OF 46 PATIENTS WITH ANTI-(U1)snRNP ANTIBODIES 1994 ·Lara D. Veeken ·F.H.J. van den Hoogen,Peter E. Spronk,A M Boerbooms,Hendrika Bootsma,(unknown),C. G. M. Kallenberg,L.B.A. van de Putte	46
14	Applicability of Saliva as a Diagnostic Fluid in Sjögren's Syndrome 1993 ·Annals of the New York Academy of Sciences ·Arjan Vissink,A.K. Panders,J.M. Nauta,(unknown),Peter G. J. Nikkels,C. G. M. Kallenberg	17
15	Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model. 1993 ·The Journal of Experimental Medicine ·Elisabeth Brouwer,Minke G. Huitema,Pieter A. Klok,Henk de Weerd,J. W. Cohen Tervaert,Jan J. Weening,C. G. M. Kallenberg	153
16	Induction of an Humoral and Cellular (Auto) Immune Response to Human and Rat Myeloperoxidase(MPO) in Brown-Norway(BN), Lewis and Wistar Kyoto(WKY) Rat Strains 1993 ·Advances in experimental medicine and biology ·(unknown),Jan J. Weening,Pieter A. Klok,Minke G. Huitema,Jan Willem Cohen Tervaert,C. G. M. Kallenberg	7
17	Connective tissue disease in patients presenting with Raynaud's phenomenon alone. 1991 ·Annals of the Rheumatic Diseases ·C. G. M. Kallenberg	10
18	Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis? 1991 ·Immunology Today ·C. G. M. Kallenberg,Jan Willem Cohen Tervaert,Fokko J. van der Woude,Roel Goldschmeding,A. E. G. Kr. v. d. Borne,Jan J. Weening	64
19	Criteria for disease activity in Wegener's granulomatosis: A requirement for longitudinal clinical studies 1990 ·Apmis ·C. G. M. Kallenberg,J. W. Cohen Tervaert,Coen A. Stegeman	25
20	Lymphocyte subpopulations in peripheral blood and bone marrow in patients with idiopathic myelofibrosis 1987 ·Annals of Hematology ·Edo Vellenga,S Poppema,C. G. M. Kallenberg,M. R. Halie	2

About C. G. M. Kallenberg

C. G. M. Kallenberg is a scholar working on Rheumatology, Immunology and Nephrology, having authored 74 papers that have together received 7.2k indexed citations. Recurring topics across this work include Vasculitis and related conditions (32 papers), Systemic Lupus Erythematosus Research (19 papers) and Renal Diseases and Glomerulopathies (8 papers). The work is most often cited by research in Rheumatology (3.1k citations), Pulmonary and Respiratory Medicine (4.4k citations) and Nephrology (936 citations). C. G. M. Kallenberg has collaborated with scholars based in Netherlands, United States and Italy. Frequent co-authors include Gary S. Hoffman, P A Bacon, Jacob Churg, J. Charles Jennette, Robert T. McCluskey, Wolfgang L. Gross, Ronald J. Falk, Leendert A. van Es, Rüdiger Waldherr and Allan Wiik. Their work appears in journals such as The Lancet, The Journal of Experimental Medicine and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact